Organic Flower Investments Group Inc. announced the Company has entered into a definitive sub-licensing agreement (the “Agreement”) with 1205293 B.C. Ltd. d/b/a True Focus Canada Under the terms of the Agreement, Organic Flower has been granted an exclusive sub-license, which permits the domestic marketing, distribution and development of True Focus’ product suite and proprietary intellectual property (“IP”) portfolio. The aforementioned sub-license covers the territory of Canada, and shall be effective for a period of 10 years from the date of grant. True Focus boasts a suite of all-natural, nutraceutical formulations, coupled with an intuitive delivery system designed to mitigate the negative side effects associated with excessive tetrahydrocannabinol (“THC”) consumption. True Focus’ product formulations are considered ‘patent-pending’ by way of a United States Patent and Trademark Office (“USPTO”) patent application. Recreational cannabis consumption for the purpose of achieving desired levels of euphoric or psychoactive effects, can at times lead to adverse and unwanted side effects, given the lack of consistent doses distinction or historical use. True Focus’ patent-pending formulation offers a unique solution to alleviating undesirable symptoms associated with a THC overdose.